We are monitoring the impact of COVID-19 on MEA IVF Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 263
Share on
Share on

Middle East and Africa In-Vitro Fertilization Market Research Report - By Reagents & Media, Instruments, Technology, End Users & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 263
Pages: 145

MEA IVF Market Size (2021 to 2026)

The Middle East and Africa In-Vitro Fertilization Market size is expected to reach USD 0.55 billion by 2026 from USD 0.26 billion in 2021, growing at a CAGR of 16.64% from 2021 to 2026.

The high rate of healthcare GDP, increase in the average age of the first child, drop-in infertility rates, rising cases of young people suffering from non-communicable diseases such as polycystic ovary syndrome, diabetes, increasing incidence of obesity, favorable fertility tourism, and government initiatives are the factor responsible for the positive growth of the MEA IVF market. However, globally, the birth rate is declining due to various factors such as the increasing age-related infertility and preference for late marriage and children. According to the United Nations, the UAE's current birth rate in 2021 is 10,112 births per 1,000 people, down 0.88% from 2020. In 2020, the regional birth rate was at 10,200 births per 1,000 people, down by 0.88% from the year 2019. While in 2019, the birth rate was recorded at 10,291 births per 1,000 people, down 0.87% from 2018. Thus, the decline in the birth rate can be attributed to rising in infertility, leading to a significant increase in demand for IVF treatments for both men and females.

In women, the chances of conceiving decrease after age 32, and by the age of 40, fertility rates are halved; likewise, in men between the ages of 20 and 80, semen volume and sperm motility decrease. Therefore, women who delay pregnancy are at increased risk of low birth weight, miscarriage, fetal abnormalities, premature labor, still birth, prolonged labor, and maternal morbidity. According to a new report, the fertility rate across the globe was at 10%, and the percentage was at a high of 15% or more in the Middle East and African region. Also, infertility in males is growing with an increased number of nearly 50%, and these cases are due to lifestyle, lack of exercise, diabetes, obesity, and genetics-related factors. All the factors mentioned above are anticipated to drive the MEA IVF market for the next few years.

According to a study from the Advanced Fertility Center in Chicago, 1 in 4 women is infertile by 35. The study indicates that the pregnancy rate gradually declines in your 30s and drops sharply over the past 30 and 40 years. Additionally, it can be noted that the success rate of a single IVF cycle is limited, where many couples try multiple processes. Decreasing the success rates of IVF treatment procedures with increasing patient age is a significant challenge for fertility treatment technologies. Additionally, complications associated with IVF treatment and inadequate reimbursement options will restraint the market during the forecast period.

This research report on the Middle East and Africa In-vitro fertilization market has been segmented and sub-segmented into the following categories:

By Reagents and Media: 

  • Embryo Culture Media
  • Cryopreservation Media
  • Sperm Processing Media
  • Ovum Processing Media                   

By Instruments: 

  • Imaging Systems
  • Sperm Separation Systems
  • Ovum Aspiration Pumps
  • Incubators
  • Micromanipulator Systems
  • Cryosystems
  • Other Instruments (Gas Analyzers, Laser Systems, Accessories)                     

By Technology: 

  • Intra-Cytoplasmic Sperm Injection (ICSI)
  • Pre-Implantation Genetic Diagnosis (PGD)
  • Frozen Embryo Transfer/Replacement (FET/FER)
  • Other Technologies                             

By End Users: 

  • Fertility and Surgical Centers
  • Hospitals and Research Laboratories
  • Cryobanks                               

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the Saudi Arabian market is expected to be the largest market share in the MEA IVF market. This market growth can be attributed to the decline in the birth rate, the growing number of government-backed fertility clinics and infertility services, and increased product launches are expected to boost the regional market. Saudi Arabia's current birth rate in 2021 is 16,630 births per 1,000 people, a decrease of 2.73% from 2020. While in the year 2020, the birth rate was at 17,097 births per 1,000 people, a reduction of 2.65% compared to 2019. The markets are anticipated to grow and gather new opportunities with collaborations between international players and the regional government for healthcare awareness.

In the UAE, the regional market will grow with the highest CAGR during the projected period, owing to increasing rates of obesity and polycystic ovary syndrome, delayed marriages, better reimbursement policies, and increased IVF tourism. According to a recent report, medical tourism represents 12 to 16% of the volume of IVF patients.  Additionally, the growing number of product launches and medications are expected to boost the UAE IVF market.

KEY MARKET PLAYERS:

Companies playing a notable role in the MEA In-Vitro Fertilization Market covered in this report are CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), EMD Serono, Inc. (U.S.), Genea Limited (Australia), ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), and The Baker Company, Inc. (U.S.).

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 Introduction                                               

                5.2 Reagents and Media                                              

                                5.2.1 Introduction                           

                                5.2.2 Embryo Culture Media                       

                                5.2.3 Cryopreservation Media    5.2.2.1 Autologous Cell-Based Products

                                5.2.4 Sperm Processing Media   5.2.2.2 Allogeneic Cell-Based Products  

                                5.2.5 Ovum Processing Media                   

                5.3 Instruments                                               

                                5.3.1 Introduction                           

                                5.3.2 Imaging Systems                  

                                5.3.3 Sperm Separation Systems                              

                                5.3.4 Ovum Aspiration Pumps                   

                                5.3.5 Incubators                               

                                5.3.6 Micromanipulator Systems                              

                                5.3.7 Cryosystems                          

                                5.3.8 Other Instruments (Gas Analyzers, Laser Systems, Accessories)                     

                5.4 Technology                                 

                                5.3.1 Introduction                           

                                5.3.2 Intra-Cytoplasmic Sperm Injection (ICSI)                   

                                5.3.3 Pre-Implantation Genetic Diagnosis (PGD)                               

                                5.3.4 Frozen Embryo Transfer/Replacement (FET/FER)                  

                                5.3.5 Other Technologies                             

                5.5 End Users                                    

                                5.4.1 Introduction                           

                                5.4.2 Fertility and Surgical Centers                           

                                5.4.3 Hospitals and Research Laboratories                           

                                5.4.4 Cryobanks                               

  1. Geographical Analysis

                6.5.1 Introduction                                           

                6.5.2 Middle East                                             

                6.5.2 South Africa                                            

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1 CooperSurgical, Inc. (U.S.)                                   

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Cook Medical, Inc. (U.S.)                                      

                8.3 Irvine Scientific (U.S.)                                             

                8.4 Vitrolife AB (Sweden)                                            

                8.5 Thermo Fisher Scientific, Inc. (U.S.)                                 

                8.6 EMD Serono, Inc. (U.S.)                                        

                8.7 Genea Limited (Australia)                                    

                8.8 ESCO Micro Pte. Limited (Singapore)                                               

                8.9 IVFtech ApS (Denmark)                                        

                8.10 The Baker Company, Inc. (U.S.)                                       

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

     Appendix                                                          

a) List of Tables

b) List of Figures

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East and Africa In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  2. Middle East and Africa In-Vitro Fertilization Market, By Reagents and Media, From 2021 to 2026 (USD Billion)
  3. Middle East and Africa Embryo Culture Media In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  4. Middle East and Africa Cryopreservation Media In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  5. Middle East and Africa Sperm Processing Media In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  6. Middle East and Africa Ovum Processing Media In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  7. Middle East and Africa In-Vitro Fertilization Market, By Instruments, From 2021 to 2026 (USD Billion)
  8. Middle East and Africa Imaging Systems In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  9. Middle East and Africa Sperm Separation Systems In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  10. Middle East and Africa Ovum Aspiration Pumps In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  11. Middle East and Africa Incubators In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  12. Middle East and Africa Micromanipulator Systems In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  13. Middle East and Africa Cryosystems In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  14. Middle East and Africa Other Instruments In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  15. Middle East and Africa In-Vitro Fertilization Market, By Technology, From 2021 to 2026 (USD Billion)
  16. Middle East and Africa Intra-Cytoplasmic Sperm Injection In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  17. Middle East and Africa Pre-Implantation Genetic Diagnosis In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  18. Middle East and Africa Frozen Embryo Transfer/Replacement In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  19. Middle East and Africa Other Technologies of In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  20. Middle East and Africa In-Vitro Fertilization Market, By End Users, From 2021 to 2026 (USD Billion)
  21. Middle East and Africa Fertility and Surgical Centers In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  22. Middle East and Africa Hospitals and Research Laboratories In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  23. Middle East and Africa Cryobanks In-Vitro Fertilization Market, By Region, From 2021 to 2026 (USD Billion)
  24. Middle East In-Vitro Fertilization Market, By Instruments, From 2021 to 2026 (USD Billion)
  25. Middle East In-Vitro Fertilization Market, By Technology, From 2021 to 2026 (USD Billion)
  26. Middle East In-Vitro Fertilization Market, By End Users, From 2021 to 2026 (USD Billion)
  27. Africa In-Vitro Fertilization Market, By Reagents and Media, From 2021 to 2026 (USD Billion)
  28. Africa In-Vitro Fertilization Market, By Instruments, From 2021 to 2026 (USD Billion)
  29. Africa In-Vitro Fertilization Market, By Technology, From 2021 to 2026 (USD Billion)
  30. Africa In-Vitro Fertilization Market, By End Users, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample